Prosecution Insights
Last updated: October 27, 2026

POET Research Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Analysis

POET Research Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 examiners and 5 art units, showing a broadly distributed docket with one examiner handling more than one pending matter.

MONSHIPOURI, MARYAM is the busiest examiner, with 2 pending matters. Counsel should examine those related records for consistent treatment while maintaining coordinated strategy across the other assigned examiners and units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
3
Medium (60%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
Double-patenting + other2 (40%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MONSHIPOURI, MARYAM 2 79.2% +37.2%
ESPERON, NATHAN GREGORY 1 41.0% +23.3%
UNDERDAHL, THANE E 1 58.8% +50.2%
GWARTNEY, ELIZABETH A 1 36.0% +34.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17199274 ENZYMATIC DEGRADATION OF MYCOTOXINS DURING GRAIN PROCESSING GWARTNEY, ELIZABETH A 9d overdue
18746445 METHODS AND SYSTEMS FOR SEPARATING OIL FROM ONE OR MORE STILLAGE COMPOSITIONS MONSHIPOURI, MARYAM —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18086350 ENZYME PRODUCTION USING ONE OR MORE CO-PRODUCT COMPOSITIONS FROM A BIOPROCESSING FACILITY MONSHIPOURI, MARYAM 24d overdue
17365027 ECONOMIC SUGAR STREAM, PROCESSES AND SYSTEMS OF PRODUCING SAME UNDERDAHL, THANE E 9d overdue
17199274 ENZYMATIC DEGRADATION OF MYCOTOXINS DURING GRAIN PROCESSING GWARTNEY, ELIZABETH A 9d overdue
18454368 METHODS AND SYSTEMS FOR PROPAGATING MICROORGANISMS FOR MITIGATING MYCOTOXIN CONTAMINATION, AND RELATED SYSTEMS AND METHODS ESPERON, NATHAN GREGORY 9d
18746445 METHODS AND SYSTEMS FOR SEPARATING OIL FROM ONE OR MORE STILLAGE COMPOSITIONS MONSHIPOURI, MARYAM —

Top Art Units

Art UnitApps
1651 2
1799 1
1699 1
1759 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18746445 METHODS AND SYSTEMS FOR SEPARATING OIL FROM ONE OR MORE STILLAGE COMPOSITIONS MONSHIPOURI, MARYAM 1651 §103§112 Non-Final OA — Pending Jun 18, 2024
18454368 METHODS AND SYSTEMS FOR PROPAGATING MICROORGANISMS FOR MITIGATING MYCOTOXIN CONTAMINATION, AND RELATED SYSTEMS AND METHODS ESPERON, NATHAN GREGORY 1799 §103 Final Rejection 9d Pending Aug 23, 2023
18086350 ENZYME PRODUCTION USING ONE OR MORE CO-PRODUCT COMPOSITIONS FROM A BIOPROCESSING FACILITY MONSHIPOURI, MARYAM 1651 §112DP Final Rejection 24d overdue Pending Dec 21, 2022
17365027 ECONOMIC SUGAR STREAM, PROCESSES AND SYSTEMS OF PRODUCING SAME UNDERDAHL, THANE E 1699 §102§103DP Non-Final OA 9d overdue Pending Jul 01, 2021
17199274 ENZYMATIC DEGRADATION OF MYCOTOXINS DURING GRAIN PROCESSING GWARTNEY, ELIZABETH A 1759 §103§112 Non-Final OA 9d overdue Pending Mar 11, 2021

Managing POET Research Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does POET Research Inc. have?

POET Research Inc. has 5 pending office actions as of October 2026, spread across 4 art units and 4 examiners.

Which USPTO examiner handles the most POET Research Inc. applications?

Maryam Monshipouri has the most, with 2 of POET Research Inc.'s pending office actions.

What technology area are POET Research Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month